We studied the clinical use of an automatic feedback control system to adjust the end-tidal anaesthetic concentration with a low-¯ow method. The end-tidal controller uses two input signals (the end-tidal and inspiratory concentrations) to control the iso¯urane concentration in the fresh gas¯ow, using a model-based algorithm. We studied 22 ASA I±III patients during elective surgery lasting more than 2 h. The anaesthetist was asked to make four step changes of the target end-tidal concentration (+0.3, +0.6, ±0.3, ±0.6 vol%), either manually (Group A) or by setting the target value for the feedback controller (Group B), and then the control was changed and the step changes were repeated, in a crossover design. Eighty step changes with each control method were compared in terms of response time, maximal overshoot and stability. The automatic control system was more accurate and stable than the human controller for step increases and step decreases, with less overshoot/undershoot and greater stability [e.g. maximal overshoot 14.7 (SD 3.7)% and 18 (8.1)% respectively for +0.6 vol% step changes, and 19.8 (3.7)% and 30.7 (13.2)% respectively for +0.3 vol% step changes]. However, the automatic control system showed a faster response time than the manual method only with large increasing steps (e.g. 149 (32) s and 205 (57) s respectively for +0.6 vol% step changes) and was not different from manual control for decreasing steps. Automatic control of the end-tidal iso¯urane concentration can be better than human control in a clinical setting, and this task could be done automatically.
are more stable. 9 During the induction of anaesthesia, the inspired concentration is often set well above the desired brain tension to speed the induction process (the overpressure technique). 10 We set a control system to adjust the end-tidal anaesthetic concentration for a variety of surgical interventions and patient characteristics, and compared it with manual control.
Methods

Patients
With institutional ethics committee approval and written, informed consent from the subjects, we studied 22 ASA I±III patients (18±75 yr) undergoing elective surgical procedures (neurosurgery, ENT, abdominal and orthopaedic surgery). We excluded patients with a history of coronary artery disease or with arterial hypertension that was poorly controlled.
The patients were given lorazepam 1±2 mg orally 30 min before induction of anaesthesia. An i.v. cannula was placed in a peripheral vein, and we monitored 3-lead ECG, arterial pressure (either non-invasively or invasively, at the discretion of the anaesthetist), and pulse oximetry. Anaesthesia was performed by experienced anaesthetists with more than 2 yr of training.
The patients were assigned randomly (by lot) to one of two treatment groups for the ®rst phase of anaesthesia. Group A patients were anaesthetized by manual adjustment of the concentration of iso¯urane. Group B patients were anaesthetized with an automatic feedback control system to adjust the end-tidal iso¯urane concentration.
The anaesthetist was asked to make four step changes of the target end-tidal iso¯urane concentration, either manually or by setting the target value for the feedback controller, after the beginning of surgery. The anaesthetists were in a realistic clinical situation and had to make the changes as best they could while ful®lling other clinical tasks. Before the ®rst step change and after each subsequent step, an equilibration period of approximately 10 min was allowed so that a constant end-tidal concentration could be maintained. The end-tidal target concentration was increased in two steps (+0.3 and +0.6 vol%) and decreased in two steps (±0.3 and ±0.6 vol%).
The sequence of the four step changes was chosen by the anaesthetist according to clinical needs and anticipated surgical stimulation, but the chosen step had to be sustained for a minimum time of 10 min. If the mean arterial blood pressure decreased by more than 20% after an increasing step-change, a single dose of ephedrine (5 mg i.v.) was allowed or an equivalent decreasing step-change of the endtidal iso¯urane concentration was sought. If the mean arterial pressure increased by more than 20% after a decreasing step change, additional fentanyl (1±2 mg kg ±1 ) was given.
After this ®rst phase of four step changes, the method of adjusting the end-tidal iso¯urane concentration was changed to the other method for a second phase, i.e. patients randomized to Group A (manual control) were now assigned to the automatic feedback control system for the next four step changes, and vice versa for Group B patients.
After a total of eight changes, the study ®nished and control continued with the second method. All the changes were made within the ®rst 2 h of surgery. All changes were within a range of 0.3±1.2 vol% of the end-tidal iso¯urane concentration.
Anaesthesia was induced with fentanyl (2 mg kg ±1 ) and thiopental (3±5 mg kg ±1 ). The trachea was intubated after muscle relaxation with vecuronium (0.1 mg kg ±1 ). Additional doses of vecuronium were given to maintain 0±2 responses of TOF stimulation at the ulnar nerve. After tracheal intubation, controlled ventilation was adjusted to maintain the end-tidal carbon dioxide at 4.5% (®xed respiratory rate of 10 per min, tidal volume variable), and anaesthesia was maintained with 70% N 2 O in oxygen, iso¯urane and boluses of fentanyl (1±2 mg kg ±1 ) as necessary.
After tracheal intubation, the fresh gas¯ow was set to 6 litre min ±1 . Ten minutes later the¯ow was reduced to 1 litre min ±1 and at the end of the surgery it was reset to 6 litre min ±1 in both groups. The control system was started after the beginning of the operation. An equilibration period of 10 min was allowed for initialization of the controller before step changes of the end-tidal iso¯urane concentration were undertaken. The sampling frequency for data collection was 10 per min, corresponding to a respiratory rate of 10 per min.
The control system
We used the Cicero workstation (Dra Ègerwerke, Germany) with an iso¯urane vaporizer (Dra Èger Vapour 19.3). It is able to monitor the following values: ECG, arterial pressure, pulse oximetry and sidestream measurements of oxygen, nitrous oxide, iso¯urane and other inhalation agents. For safety reasons, iso¯urane, nitrous oxide and oxygen concentrations were also measured with a sidestream anaesthetic gas analyser (Datex Capnomac; AVL, Switzerland). Both sampling lines were connected to a stopcock at the breathing ®lter (HME ®lter, nos 22 and 25; PALL, Switzerland) ®tted to the endotracheal tube. All analysers were calibrated before use, according to the instructions of the manufacturers.
The end-tidal controller is a model-based state feedback controller (see Appendix A), uses two input signals (endtidal and inspiratory iso¯urane concentrations) and produces one output signalÐthe iso¯urane concentration in the fresh gas supply, i.e. the vaporizer setting. The Dra Èger 19.3 vaporizer is adjusted by an external servo-motor. The servomotor itself is driven by an analogue ampli®er controlled by a PID (Proportional Integral Derivative; for explanation see Feedback control of end-tidal iso¯urane Appendix A), which in turn is controlled by a conventional electronic interface. The vaporizer and the PID control system are calibrated so that known concentrations are delivered in response to the input voltage. Two Hi-Tech (Bronkhorst Hi-Tech, Ruurlo, Netherlands) nitrous oxide and oxygen mass¯ow controllers are used to supply a precise¯ow of gases. They are able to deliver gas¯ows between 0 and 10 litre min ±1 with T1% accuracy. The anaesthetist can control the feedback system with a touchscreen panel. This panel has buttons for the selection of the end-tidal iso¯urane concentration and the fresh gas ow. The Cicero vaporizer and¯owmeters are bypassed when the feedback control system is operating. However, the anaesthetist can revert to manual control at any time.
The control algorithms are implemented on a VME-board power PC using the real-time programming language XOberon (Institute of Robotics, Swiss Federal Institute of Technology, Zurich, Switzerland). Dedicated parts of the program are used to send data for display and storage to a standard PC via an Ethernet link.
Data analysis
The control of the end-tidal iso¯urane concentration was judged by comparing the step changes of the target end-tidal iso¯urane concentration under the two modes of control (manual/automatic feedback), using the following performance criteria (Tables 2 and 3). 1. Response time: time to reach the target value: (a) increasing step change: time to reach the target value, from 10 to 90% of the step height (e.g. for an increasing step change of 0.6%, from 0.5 to 1.1%, the response time would be de®ned as the time to reach 1.04% from 0.56%);
(b) decreasing step change: time to reach the target value, from 10 to 90% of the step height (e.g. for a decreasing step change of 0.3%, from 0.8 to 0.5%, the response time would be de®ned as the time to reach 0.53 from 0.77%).
2. Maximal overshoot/undershoot: maximum amount the system overshoots or undershoots its target value, expressed as a percentage of the step height. Observation starts after the target value has been reached for the ®rst time.
3. Stability: deviation of the measured end-tidal isourane concentration from the target value, expressed as percentage frequency distributions of the deviation (measured minus desired) of the end-tidal iso¯urane concentration. Observation starts after the target value has been reached for the ®rst time.
The number of changes of the vapour setting (b0.05 vol%) was also recorded.
Numerical variables in the two groups were compared by the paired t-test when data were normally distributed, otherwise the Wilcoxon signed rank test was used. A P value <0.05 was considered statistically signi®cant. The statistical package used was Sigma Stat, version 2.0 (Jandel Corporation, San Rafael, California, USA). Sieber et al.
Results
The two groups were similar with respect to sex, age, weight and duration of surgery (Table 1) . In both groups, two patients had only one series of step changes because the operation ®nished early. The remaining 18 patients were studied after the protocol, i.e. they all had four step changes performed in the manual and in the automatic mode. Therefore, a total of 80 step changes were analysed in each group.
The performance of the feedback control was superior to that of the manual control in terms of overshoot and stability, with increasing as well as decreasing step changes (Tables 2 and 3 and Figs 1, 2, 3 and 4) . The response time for the increasing step changes was shorter in the automatic mode for the larger steps only; for the smaller steps it was shorter in the manual mode. The response time for the decreasing step changes did not differ statistically between the two groups.
The automatic control of the end-tidal iso¯urane concentration resulted in higher numbers of changes of the vapour setting, for increasing as well as decreasing step changes (only with decreasing steps of 0.6 vol% was the difference not statistically signi®cant).
We observed a total of 19 artefacts during the automatic control mode. These artefacts were caused by the calibration process and were all handled successfully by the end-tidal controller. Figure 5 shows an untreated artefact during a pilot study. Figure 6 shows a suppressed artefact in a study patient.
One patient in Group A and two patients in Group B required ephedrine to treat a decrease in mean arterial blood pressure of more than 20%. 
Feedback control of end-tidal iso¯urane
Discussion
The automatic control system of end-tidal iso¯urane was generally faster, more stable and more accurate than human control.
The response time for increasing step changes was faster with automatic control than with manual control except for the small (+0.3 vol%) step changes. The slower response time of the automatic control for the small step changes was caused by the control algorithm, which only allowed a stepwise increase in the vaporizer setting, whereas with manual control the vaporizer setting was often immediately turned up to the maximum position. In a control system, there is a trade-off between the response time and the overshoot/stability of control. We judged that stability and accuracy of control should have priority over speed. Nevertheless, for the larger increasing step changes, the automatic control was faster and more reliable. With decreasing step changes there was no difference in the response time of the two modes. This is no surprise, as the rate of decrease of the end-tidal iso¯urane concentration is determined by patient uptake and cannot be in¯uenced directly unless the fresh gas¯ow is adjusted.
Stability and accuracy are the important clinical features of an automatic control system. Large changes in the control variable can either jeopardize the patient by an overdose or expose the patient to the risk of awareness. The clinical signi®cance of the better performance of the automatic controller lies in the more reliable avoidance of minimal and maximal values of the control variable, whereas in the midrange it does not make a great difference.
The model used in this study, with its 12 physiological compartments, is fairly complex. A less complex model derived from input/output measurements, like the one described by Yasuda and colleagues, 11 could perhaps give similar results. However, we plan to extend the automatic control application to children and less ®t patients, for whom physiologically based models are easier to adjust to speci®c patient characteristics.
Complex control systems should reduce work and increase safety, but they will not do so in all situations or circumstances. An important safety issue is the handling of artefacts. Measurement artefacts can degrade controller performance or lead to hazardous situations for the patient. 
Fig 6
Example of the successful suppression of a calibration artefact, occurring during a decreasing step change in a study patient. Despite a prolonged calibration process, of approximately 2 min, the end-tidal iso¯urane controller was not disturbed by the temporary lack of incoming data and the end-tidal iso¯urane concentration slope continued to fall as if no data loss had occurred.
Fig 5
Example of an untreated calibration artefact, occurring during a decreasing step change in a pilot study. Because of the artefact, the endtidal controller overshot the target value for a short period.
Artefacts are quite common in clinical practiceÐfor example, kinking of the gas sample tube. In our case, nonlinear weighting of the error signal was used to make the model-based control algorithms tolerant of measurement artefacts. 12 When activated, the controller was able to suppress the in¯uence of any artefact that occurred during the study.
Efforts to reduce the cost of inhalation agents by encouraging clinicians to use low fresh gas¯ows have not been very successful in the long term, 13 14 mostly because of lack of continued feedback. Carefully constructed practice guidelines seem to be promising, 15 16 but they can be dif®cult to introduce and are not in widespread use. A feedback control system for the end-tidal concentration of an inhalation agent would encourage low-¯ow systems and could be cost-effective.
Human control and intervention are still required to specify the appropriate depth of anaesthesia and to respond to crises. However, liberating the anaesthetist from those tasks that can be automated should improve safety by allowing the anaesthetist more time for other aspects of anaesthesia care.
feedback control algorithm has some similarities to a classical PID controller. In such a controller, the control action has three components: (i) an action which is proportional (hence`P') to the error between the set point and the system output; (ii) an action proportional to the integral (hence`I') of this error; and (iii) an action that is proportional to the derivative (hence`D') of this error. In the case of the augmented state feedback controller, the feedforward term (F) plays an analogous role as the P part. The integral term acts identically in both types of controller. The state feedback acts like a derivative term. The important difference is that it does not introduce just ®rst-order derivative action but rather derivatives up to an order equal to the number of states in the state vector x(t). This makes it possible to design considerably more aggressive controllers.
Because in most cases the states of the system (e.g. the partial pressure of iso¯urane within an organ) cannot be measured, an`observer' (parallel model of the system to be controlled) is used to compute an estimate of the states (x Ã(t)). This state estimate is then used in the control algorithm instead of the actual state. The state estimates usually differ from the true states because an observer cannot fully describe the reality and the initial conditions are not known precisely. To achieve fast convergence of the state estimates towards the true states, a correction gain (L) is introduced. This gain leads to correction of the state estimates based on the difference between the measurements and the predictions of the parallel model. Note that in our case the measurements refer to the measurement vector y(t), which contains the inspired as well as the end-tidal iso¯urane concentration measurement. Typically, L is a constant gain which must be chosen so that the rate of convergence of the state estimation is faster than the desired response of the controller. Using a non-linear-modi®ed gain, however, artefacts can be rejected easily. 12 
Appendix B
Model
The pharmacokinetic and pharmacodynamic model description was obtained by adjusting the compartmental model for halothane described by Smith and colleagues 19 to iso¯urane and by augmenting it with a dynamic representation of the respiratory circuit. The adjustment to iso¯urane was done by means of published iso¯urane partition coef®cients. 20 The physiological model part describes the time-course of the partial pressure of iso¯urane in 12 body compartments. Nine compartments represent different organs grouped according to their pharmacokinetic properties with respect to iso¯urane. One compartment represents the gas exchange in the lung, and an arterial and a venous compartment are introduced to interconnect the lung and the body compartments. Together with the equation for the anaesthetic partial pressure in the respirator circuit, the state vector x(t) is derived as follows:
The dynamics of the pressure in a body compartment is described by
where l b is the solubility of iso¯urane in blood, q i (t) is the blood¯ow through the compartment, and V Ä i is a virtual distribution volume obtained as the sum of the blood and tissue volumes of the compartment, weighted with their respective solubilities. The partial pressure dynamics in the lung is given by Ç The above equations suggest that CO(t) and q i (t) are measurable as time evolves. This is not the case. Pharmacodynamic relations are used instead to compute these quantities. The corresponding equations are CO(t) = CO 0 (1 + a 1 p 1 + a 2 p 2 + a 3 p Art )
for the cardiac output and g i (t) = g i,0 (1 + b i p i ) for the conductivities of the different body compartments, from which q i (t) may be computed.
Finally where V A is the total alveolar space and V AD is the alveolar deadspace. For the design of the controller, linearizations of these equations yield the system matrices A, B, C and D. To give a more detailed description of the model in terms of parameters and validations is beyond the scope of this appendix. The interested reader is referred to reference 22 for such details.
